New Non-Executive Director appointed to CUH
Philippa Hird has been appointed as a Non-Executive Director of Cambridge University Hospitals NHS Foundation Trust (CUH), which runs Addenbrooke’s and The Rosie Hospitals.
Brain injury survivors help shape new medical technologies
Researchers based at Cambridge University Hospitals NHS Foundation Trust (CUH) have developed a programme to ensure that the development of medical technology is in line with the unmet needs of brain injury survivors.
Ireland adopts Cambridge-developed method to monitor early prostate cancer
Development of the first evidence-based tool that helps clinicians actively monitor early prostate cancer in newly diagnosed patients has won important recognition in Ireland following research in Cambridge.
Enhanced breast cancer screening could detect an extra 3,500 cancers per year
Researchers in Cambridge are calling for additional scans to be added to breast screening for women with very dense breasts. This follows a large-scale trial, which shows that extra scans could treble cancer detection for these women potentially saving up to 700 lives a year in the UK.
Call for glaucoma classification tool to be used nationally
Glaucoma is the most frequent cause of irreversible blindness but up to 40 per cent of patients could be missing out on crucial social support, warn Cambridge experts who hope their free technology will be embraced by clinicians nationally.
Robot-assisted double operation is an Addenbrooke’s first
A cancer patient who underwent the first robot-assisted double operation at Addenbrooke’s Hospital said on Tuesday 29th April “I was blown away by how fast it was all over.”
World-first trial indicates immunosuppression may help treat Parkinson’s
A groundbreaking trial, led from Cambridge, has revealed that immunosuppressing medicines show promise for the treatment of Parkinson’s disease, according to results presented this weekend at the world’s most prestigious neurodegeneration conference AD/PD.
Trust consultant honoured with Arnold Adolf Berthold award
An Addenbrooke’s honorary consultant who has won top accolades for his cutting-edge work has just been presented with another.
Doctor who shapes worldwide trauma care wins lifetime award
An Addenbrooke’s doctor who has worked on the frontline of emergency care for more than three decades – and is described as the architect of the East of England trauma network - has won a prestigious lifetime achievement award for his work.
First global pituitary study gives patients voice on research
Researchers from Cambridge and London have completed a study that is a world first of its kind and gives patients an important voice on future priorities.
CUH appoints a new Non-Executive Director
Mr John Crompton has been appointed as a Non-Executive Director of Cambridge University Hospitals NHS Foundation Trust (CUH), which runs Addenbrooke’s and The Rosie hospitals.
Trainee surgeon scoops coveted award
An Addenbrooke’s doctor who is in the final stages of training to become a vascular surgeon has been given a prestigious award for her research.
Patient who overcame brain tumour to play key role in ‘super-survivor’ cancer study
A woman from Cambridge who is living life to the full, five years after being diagnosed with an aggressive brain tumour, is hoping to take part in a trial aimed at unlocking the secrets of why some cancer patients survive longer than others.
Surgery ‘Super Sunday’ breaks operation record
A team at Addenbrooke’s Hospital has carried out a record number of gall bladder operations in a single day using high-tech robots that assist with keyhole surgery.
Children and young people “dropped down the agenda” during Covid 19 pandemic
Almost 200,000 research studies on mental health impacts were carried out during the Covid 19 pandemic, according to a Cambridge professor, but only 35 concerned children and young people, creating “a huge data gap”.
Spiderman visit is Christmas cracker for young
Supporters and staff at Addenbrooke’s are conjuring up a host of magical surprises for children in hospital this Christmas.
Trust scientist scoops award for pioneering TB research
A medical researcher and honorary consultant at Addenbrooke’s Hospital receives a top prize in Berlin for her pioneering research on tuberculosis.
Over 800 trained to ‘Restart a Heart’
More than 800 members of the public have been trained to ‘Restart a Heart’ and provide CPR –(cardiopulmonary resuscitation) which could help them save a life.
New lab to open to make cutting-edge CAR-T cells in Cambridge
A new state-of-the-art laboratory is set to open at Addenbrooke’s Hospital that will deliver ‘home-grown’ CAR-T cells to help improve treatment for blood cancers.
Research sets global standard for Crohn’s treatment
Trial results published by Cambridge researchers earlier this year and involving patients at Addenbrooke’s Hospital are helping to set new global standards for the treatment of Crohn’s disease, it has emerged.
Survivor David backs ‘Restart a Heart’ campaign
A devoted Cambridge United fan who received life-saving treatment at a packed home match has today applauded a month-long initiative aimed at teaching the public CPR – officially called cardiopulmonary resuscitation.
CUH begins ground-breaking genetic screening for newborn babies
Dozens of babies at the Rosie hospital have begun to be tested for over 200 rare genetic conditions as part of a world-leading study.
Hospital prosthetics service moves to high-tech new home
An Addenbrooke’s service that offers vital support for amputees and others officially opened on the 23rd Sept at a high-tech new home after nearly quarter of a century at the hospital.
New state-of-the-art radiotherapy equipment benefiting patients in the East
Cancer patients undergoing treatment at Norfolk and Norwich University Hospital’s NHS Foundation Trust (NNUH) and Cambridge University Hospitals NHS Foundation Trust (CUH) are benefiting from a new type of radiotherapy which reduces treatment time whilst increasing accuracy and patient comfort.
Team’s hip replacement surgery invention is set to be world first
Technology which is the first of its kind in the world and could transform the future of hip replacement surgery is being pioneered by a team of experts in Cambridge.